Navigation Links
Vion Pharmaceuticals Reports 2009 First Quarter Results
Date:5/11/2009

Company to hold Conference Call on May 14, 2009

NEW HAVEN, Conn., May 11 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced financial results for the first quarter of 2009.

The Company reported a net loss of $4.3 million, or $0.54 per share, for the quarter ended March 31, 2009, compared with a net loss of $8.2 million, or $1.14 per share, for the same 2008 period. Weighted-average common shares outstanding for the three months ended March 31, 2009 and March 31, 2008 were 7.9 million and 7.2 million, respectively.

The Company reported ending the quarter with $30.0 million in cash and cash equivalents. Based on its current operating plan, management estimates that its existing cash and cash equivalents will be sufficient to fund operations through the first quarter of 2010.

In February 2009, the Company submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for its lead anticancer agent Onrigin (laromustine) Injection for remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML). In April 2009, the Company announced that the FDA had accepted the NDA for review and that it had been assigned an end user fee date of December 12, 2009 for a decision on approval by the FDA.

Alan Kessman, Chief Executive Officer, commented, "We are continuing to interact with the FDA on our NDA with the objective of receiving approval for Onrigin in its first indication in the U.S. by the end of 2009."

Conference Call

The Company will hold a conference call at 8:30 a.m. Eastern Time on May 14, 2009 to discuss its operations and financial results.

To participate in the conference call, please dial (866) 271-6130 in the U.S. ((617) 213-8894 for international callers) at lea
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Jiangbo Pharmaceuticals Announces New Ticker (JGBO) and CUSIP
2. Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
3. Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
4. Photos: Generic Pharmaceuticals Saved $734 Billion over Last Decade
5. VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque
6. Valeant Pharmaceuticals to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
7. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
8. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
9. Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results
10. Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
11. Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... ... at Monmouth, was one of the first doctors in the area to perform ... new approach have been impressive: faster recovery, decreased immediate and long-term pain, and ...
(Date:8/31/2015)... ... ... Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as an ... from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity letters ... senior year. He was inducted into the National Honor Society as a sophomore, was ...
(Date:8/31/2015)... ... 31, 2015 , ... With the FCPX LUT Soft pack from Pixel Film Studios, editors can ... that contains a mathematical formula for modifying an image. The LUT changes every pixel's color ... LUT files. , FCPX LUT Soft requires Final Cut Pro X 10.2 or newer. ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can healthcare meet the ... costs? , In a commentary for The American Journal of Managed Care ... “clinical efficacy,” which would bind parties together in agreements to intervene at the ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
... Trust Presents Case Study for Patient Tracking System at London Conference ... ... Lombardi, a leader in http://www.lombardi.com/ [business process management (BPM) __title__ business ... been selected to present at the IRM UK,s upcoming BPM Europe ...
... 24 Andrew Engel,M.D., Roland Moskowitz, M.D., Peter ... Mayo Clinic Distinguished Alumni Award. The awards,were presented ... Alumni Association on,Sept. 11, 2008, at the Foundation ... alumni to the field of medicine,including medical practice, ...
... officials are urging more Americans than ever before to ... (HealthDay News) -- With flu season fast approaching, U.S. ... be a better match for the circulating influenza strains ... only do officials believe this year,s vaccine will be ...
... BodyTech.com hold contest for one guy and one gal to,be ... NORTH BERGEN, N.J., Sept. 24 If you,ve ever ... very, very hot in Vegas. With,the help of The Vitamin ... is offering an opportunity for two participants to,realize their dream ...
... DALLAS, Sept. 24 As the presidential political ... prevention heats up, one leading,prevention authority thinks some ... president of U.S. Preventive Medicine(R), the,leader in disease ... for itself., (Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO ), ...
... behavior in inquiries about patient mood symptoms and the ... University of Rochester Medical Center researchers. , "Some doctors, ... loathe to broach sensitive topics such as depression or ... at the Medical Center and lead author of an ...
Cached Medicine News:Health News:UCLH to Discuss Using Business Process Management to Meet Government Referral-To-Treatment Mandate at IRM BPM Europe 2008 2Health News:Mayo Clinic Announces 2008 Distinguished Alumni Awardees 2Health News:Flu Vaccine Should Be More Effective: CDC 2Health News:Flu Vaccine Should Be More Effective: CDC 3Health News:Who Will Be The 'Hot Bod' at the Olympia? 2Health News:Presidential Debate Over Health Care Costs Highlights Need for Preventive Health Care 2Health News:Presidential Debate Over Health Care Costs Highlights Need for Preventive Health Care 3Health News:Personality can hamper a physician's assessment of depression 2
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of diseases of the central nervous system ... submission has passed review by the US Food and ... 1 clinical trial in patients with metastatic colon cancer ... 31 December 2015. Bionomics, CEO & Managing ...
(Date:8/30/2015)... ANDOVER, Massachusetts y LONDRES, August 30, 2015 ... conectada ofrece una visión holística de l ... de todo el trayecto   ... anunciado hoy el debut europeo de IntelliSpace Cardiovascular ... información que ofrece sofisticadas herramientas para acceder, analizar y ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
... RALEIGH, N.C., Nov. 15, 2010 PRA International, a ... experts will lead a panel at the 9th annual ... 17-18 November 2010. PRA, a co-sponsor of the conference, ... Stansfield, Executive Vice President of PRA,s Product Registration group ...
... 2010 The Radiology journal released new ... women with newly diagnosed breast cancer that shows Positron ... study found that PEM was significantly more precise at ... "Positive Predictive Value" or "PPV," therefore reducing the number ...
Cached Medicine Technology:PRA International Expert to Chair Panel at Partnerships Conference 2Radiology Journal Publishes Data That PEM Scanners May Reduce Unnecessary Breast Biopsies and Offer an Alternative for Women Who Cannot Tolerate MRI 2
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
...
... Shoulder System* was designed to ... comprehensive range of prosthesis for ... needs. With the addition of ... offers a more complete range ...
... only shoulder prosthesis with more than ... thousands of patients. Ideal for Hemi-Arthroplasty. ... 3 or 4 part displacement fractures, ... 50%, head-splitting fractures, disabling pain unresponsive ...
Medicine Products: